221 related articles for article (PubMed ID: 33208919)
81. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
[TBL] [Abstract][Full Text] [Related]
82. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
Yao J; Zang W; Ge Y; Weygant N; Yu P; Li L; Rao G; Jiang Z; Yan R; He L; Yu Y; Jin M; Cheng G; An G
Can J Gastroenterol Hepatol; 2018; 2018():4248971. PubMed ID: 29707525
[TBL] [Abstract][Full Text] [Related]
83. Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.
Pilozzi E; Maresca C; Duranti E; Giustiniani MC; Catalanotto C; Lucarelli M; Cogoni C; Ferri M; Ruco L; Zardo G
Am J Clin Pathol; 2015 Mar; 143(3):374-84. PubMed ID: 25696795
[TBL] [Abstract][Full Text] [Related]
84. The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.
Selcukbiricik F; Erdamar S; Ozkurt CU; Molinas Mandel N; Demirelli F; Ozguroglu M; Tural D; Buyukunal E; Serdengecti S
J BUON; 2013; 18(1):116-23. PubMed ID: 23613396
[TBL] [Abstract][Full Text] [Related]
85. Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.
Lang H; Baumgart J; Heinrich S; Tripke V; Passalaqua M; Maderer A; Galle PR; Roth W; Kloth M; Moehler M
Ann Surg; 2019 Nov; 270(5):799-805. PubMed ID: 31634180
[TBL] [Abstract][Full Text] [Related]
86. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
[TBL] [Abstract][Full Text] [Related]
87. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer.
Kawaguchi Y; Kopetz S; Kwong L; Xiao L; Morris JS; Tran Cao HS; Tzeng CD; Chun YS; Lee JE; Vauthey JN
J Am Coll Surg; 2021 Aug; 233(2):272-284.e13. PubMed ID: 34111531
[TBL] [Abstract][Full Text] [Related]
88. Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
Uutela A; Nordin A; Osterlund E; Halonen P; Kallio R; Soveri LM; Salminen T; Ålgars A; Ristimäki A; Ovissi A; Lamminmäki A; Muhonen T; Kononen J; Ristamäki R; Heervä E; Stedt H; Lehtomäki K; Kytölä S; Sundström J; Mäkinen MJ; Nieminen L; Kuopio T; Keinänen M; Osterlund P; Isoniemi H;
Br J Surg; 2023 Jul; 110(8):931-935. PubMed ID: 36511370
[No Abstract] [Full Text] [Related]
89. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.
Kawaguchi Y; Newhook TE; Tran Cao HS; Tzeng CD; Chun YS; Aloia TA; Dasari A; Kopetz S; Vauthey JN
J Gastrointest Surg; 2021 Jan; 25(1):186-194. PubMed ID: 33205306
[TBL] [Abstract][Full Text] [Related]
90. K-Ras and MSI: potential markers of both patient prognosis and treatment efficacy.
Turaga K; Shibata D
Ann Surg Oncol; 2010 Feb; 17(2):354-5. PubMed ID: 19936842
[No Abstract] [Full Text] [Related]
91. Alcohol consumption, polygenic risk score, and early- and late-onset colorectal cancer risk.
Chen X; Li H; Guo F; Hoffmeister M; Brenner H
EClinicalMedicine; 2022 Jul; 49():101460. PubMed ID: 35747198
[TBL] [Abstract][Full Text] [Related]
92. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.
Takematsu T; Mima K; Hayashi H; Kitano Y; Nakagawa S; Hiyoshi Y; Okabe H; Imai K; Miyamoto Y; Baba H
J Hepatobiliary Pancreat Sci; 2024 Feb; 31(2):69-79. PubMed ID: 37897144
[TBL] [Abstract][Full Text] [Related]
93. Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study.
Di Leo M; Zuppardo RA; Puzzono M; Ditonno I; Mannucci A; Antoci G; Russo Raucci A; Patricelli MG; Elmore U; Tamburini AM; Albarello L; Azzolini F; Bonura GF; Esposito D; Fanti L; Notaristefano C; Viale E; Perea J; Testoni PA; Rosati R; Cavestro GM
Eur J Gastroenterol Hepatol; 2021 Sep; 33(9):1153-1160. PubMed ID: 33208680
[TBL] [Abstract][Full Text] [Related]
94. Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis.
Pikoulis E; Papaconstantinou D; Pikouli A; Wang J; Theodoridis C; Margonis GA
J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):637-647. PubMed ID: 34115442
[TBL] [Abstract][Full Text] [Related]
95. Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China.
Liu H; Xu H; Liu Y; Zhao Y; Zhang X; Yu Y; Du L; Liu Y; Wang W; Cao H; Ma L; Huang J; Cao J; Li L; Fan Y; Gu X; Feng C; Zhu Q; Wang X; Du J; Zhang S; Qiao Y
BMC Cancer; 2024 Apr; 24(1):503. PubMed ID: 38643082
[TBL] [Abstract][Full Text] [Related]
96. Survival outcome and prognostic factors for early-onset and late-onset metastatic colorectal cancer: a population based study from SEER database.
Ren B; Yang Y; Lv Y; Liu K
Sci Rep; 2024 Feb; 14(1):4377. PubMed ID: 38388566
[TBL] [Abstract][Full Text] [Related]
97. Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses.
Zhang S; Xu R; Hu M; Choueiry F; Jin N; Li J; Mo X; Zhu J
J Pharm Biomed Anal; 2024 Apr; 241():115978. PubMed ID: 38237540
[TBL] [Abstract][Full Text] [Related]
98. Geographic Variation and Risk Factor Association of Early Versus Late Onset Colorectal Cancer.
Dong W; Kim U; Rose J; Hoehn RS; Kucmanic M; Eom K; Li S; Berger NA; Koroukian SM
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831350
[TBL] [Abstract][Full Text] [Related]
99. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases.
Mason MC; Tzeng CD; Tran Cao HS; Aloia TA; Newhook TE; Overman MJ; Kopetz SE; Vauthey JN; Chun YS
J Am Coll Surg; 2021 Jul; 233(1):82-89.e1. PubMed ID: 33667566
[TBL] [Abstract][Full Text] [Related]
100. Associations of smoking with early- and late-onset colorectal cancer.
Li H; Chen X; Hoffmeister M; Brenner H
JNCI Cancer Spectr; 2023 Jan; 7(1):. PubMed ID: 36759940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
